Target intelligence / Profile preview

FAU pseudogene 4 (FAUP4)

Target
FAUP4
Molecular classification
Long non-coding RNA (lncRNA), Pseudogene
01

Overview

FAU pseudogene 4 (FAUP4), also referred to as PAARH, is a long non-coding RNA pseudogene located in humans. Recent studies have characterized PAARH as highly expressed in aggressive hepatocellular carcinoma and positively correlated with advanced disease features such as vascular invasion and poor survival. Mechanistically, PAARH promotes HCC tumor growth, cell proliferation, migration, and angiogenesis, partly by acting as a competing endogenous RNA (ceRNA) that increases the expression of HOTTIP, and by physically interacting with hypoxia inducible factor-1 alpha (HIF-1α) to activate vascular endothelial growth factor (VEGF) signaling under hypoxic conditions. As a result, PAARH/FAUP4 is considered both a potential prognostic biomarker and therapeutic target in HCC, representing a novel member of the growing class of functional lncRNAs in cancer biology.

Other names
PAARH (Progression and Angiogenesis Associated RNA in HCC)CMB9-22P13.1FAU pseudogene 4FAUP4
02

Mechanism of action

Drugs or molecules targeting FAUP4/PAARH could theoretically inhibit HCC cell proliferation, angiogenesis, and stemness by: Suppressing PAARH function; Reducing its ceRNA-mediated upregulation of targets (e.g., HOTTIP); Inhibiting its facilitation of HIF-1α binding to the VEGF promoter

03

Biological functions

Promotes cell proliferation and migrationInhibits apoptosis in HCC cellsRegulates angiogenesis by activating VEGF signaling via interaction with HIF-1αFunctions as a competing endogenous RNA (ceRNA), influencing gene regulatory networks
04

Disease associations

Cancer (notably hepatocellular carcinoma)Associated with tumor progression, vascular invasion, and poor prognosis in HCC
05

Safety considerations

No specific safety concerns reported for targeting FAUP4/PAARH. General challenges may include:Off-target effects common to lncRNA-targeting therapeuticsDelivery issues for nucleic acid-based therapiesImpact on normal cell regulation due to lncRNA’s complex gene network interactions
06

Biomarkers

PAARH/FAUP4 expression is a biomarker for poor prognosis, advanced stage, vascular invasion, and microvessel density in HCC

Beyond the preview

Go deeper on FAU pseudogene 4 (FAUP4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on FAU pseudogene 4 (FAUP4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call